Results 91 to 100 of about 9,597 (197)

The accuracy of the Montenegro skin test for leishmaniasis in PCR-negative patients

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2020
INTRODUCTION: As highly specific molecular biology-based techniques may not be sensitive enough for the diagnosis of American tegumentary leishmaniasis (ATL), clinicians frequently rely on immunological tests before treatment initiation.
Ana Bárbara Sapienza Pinheiro   +9 more
doaj   +1 more source

Antileishmanial Activities of Carvacrol Nanoencapsulate in Biopolymeric Nanoparticles

open access: yesChemistry &Biodiversity, Volume 22, Issue 9, September 2025.
The study obtained biopolymeric nanoparticles containing carvacrol (NPCar) and evaluated their anti‐leishmanial activity. NPCar obtained presented physicochemical characteristics due to its ideal nanometric size and zeta potential, and low polydispersity index.
Joyce Cordeiro Borges   +6 more
wiley   +1 more source

Cerebral Complication of Cutaneous Leishmaniasis: about a case

open access: yesJournal de la Faculté de Médecine d'Oran, 2022
Leishmaniasis (L) is a cutaneous, mucocutaneous, or visceral disease caused by intracellular Leishmania protozoan parasites that are transmitted by the bite of female sand flies.
Schahrazed Linda MAGUENOUCHE   +2 more
doaj  

Resistance to Oxidative Stress Is Associated with Metastasis in Mucocutaneous Leishmaniasis [PDF]

open access: yes, 2017
Mucocutaneous leishmaniasis (MCL) in South and Central America is characterized by the dissemination (metastasis) of Leishmania Viannia subgenus parasites from a cutaneous lesion to nasopharyngeal tissues.
Acestor, Nathalie   +5 more
core  

An unusual presentation of leishmaniasis in a human immunodeficiency virus-positive individual [PDF]

open access: yes, 2016
INTRODUCTION: Leishmaniasis is a neglected tropical disease caused by vector-borne protozoa of the genus Leishmania. Cutaneous and mucocutaneous forms result in disfiguration or mutilation, whilst visceral leishmaniasis (VL) affects multiple organs ...
Davis, Thomas E.   +5 more
core   +1 more source

Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report

open access: yesMemorias do Instituto Oswaldo Cruz, 2004
Severe mucocutaneous (MCL) and diffuse (DCL) forms of American cutaneous leishmaniasis (ACL) are infrequent in Venezuela. Chemotherapy produces only transitory remission in DCL, and occasional treatment failures are observed in MCL.
Jacinto Convit   +6 more
doaj   +1 more source

Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review

open access: yesDermatology Research and Practice, 2018
The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalent antimonials, sodium stibogluconate, or meglumine antimoniate.
Taisa Rocha Navasconi Berbert   +10 more
doaj   +1 more source

Dermatologic and otorhinolaryngologic manifestations in leishmaniasis

open access: yesInternational Archives of Otorhinolaryngology, 2011
Introduction: Leishmaniasis is an extremely important parasitic disease as regards epidemiology, and, in such a disease, man is an occasional host to the Leishmania protozoon.
Mota, Luiz Alberto Alves   +1 more
doaj  

Leishmaniasis in humans and small animals: Updates and insights through a one health

open access: yesLetters in Animal Biology
Leishmaniasis is neglected infectious disease caused by a type of microscopic parasite called Leishmania spp. This disease can affect both humans and animals, as well as sandflies.
Amirhossein Badkoubi   +6 more
doaj   +1 more source

Nouvelles de la SSDV / Neues aus der SGDV [PDF]

open access: yes, 2005
Im Rahmen des nationalen Programms zur Bekämpfung von Hautkrebs richtete die Krebsliga Schweiz einen Bus ein, der sich in verschiedenen Städten aufhielt.
Bulliard, Jean-Luc   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy